Characterizing the Early Drug Development Outsourcing Landscape Stella Stergiopoulos, Tufts Center for the Study of Drug Design, speaking at Drug Discovery and Development 2014
Towards an Exosomes-based Molecular Test for Remission Monitoring of Cancer Michiel Pegtel, VU University Medical Center, speaking at Molecular Medicine Congress 2013.
Multiplexed Measurement of Disease Biomarkers by Mass Spectometry (MRM) for Predictive and Prognostic Purposes Stephen Pennington, University College Dublin, speaking at Molecular Medicine Congress 2013.
Mass Spectrometry Imaging of Single Cells in Mouse Models of ALS Jeffrey Agar, Brandeis University, speaking at Single Cell Analysis Summit 2013.
Proteomic Analysis of Pathways Involved in Hematophoeisis and Leukaemic Transformation Anthony Whetton, Manchester University, speaking at Systems Biology Europe.
Chemical Biology Approaches to Target Protein Modification in Disease Megan Wright, Imperial College London, speaking at Discovery Chemistry Congress 2013.
Guiding Treatment Decisions in Cancer using Protein Biomarker Measurements: from Design to Utility Prof. Stephen Pennington, University College Dublin, speaking at Discovery Chemistry Congress 2013.
Chemical Proteomics: Drug Targets, Drug Selectivity, MoA and Resistance Dr. Guillaume Médard, Technische Universität München, speaking at Discovery Chemistry Congress 2013.
Typical Phospho-form Abundance Profile of Cellular ERK Discovered by Quantitative UPLC-MS Wolf Lehmann, German Cancer Research Center, speaking at Systems Biology Europe 2012